prikaz prve stranice dokumenta Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future
  Preuzmi
PDF 518.8 KB
Znanstveni rad - Izvorni znanstveni rad
Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future
Expert Review of Pharmacoeconomics & Outcomes Research, 16 (2015), 5; 609-618. https://doi.org/10.1586/14737167.2016.1115347
Marković-Peković, Vanda; Škrbić, Ranko; Petrović, Aleksandar; Vlahović-Palčevski, Vera; Mrak, Jana; Bennie, Marion; Fadare, Joseph; Kwon, Hye-Young; Schiffers, Krijn; Truter, Ilse; Godman, Brian

Citirajte ovaj rad

Marković Peković, V., Škrbić, R., Petrović, A., Vlahović Palčevski, V., Mrak, J., Bennie, M. ... Godman, B. (2015). Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future. Expert Review of Pharmacoeconomics & Outcomes Research, 16. (5), 609-618. doi: 10.1586/14737167.2016.1115347

Marković Peković, Vanda, et al. "Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future." Expert Review of Pharmacoeconomics & Outcomes Research, vol. 16, br. 5, 2015, str. 609-618. https://doi.org/10.1586/14737167.2016.1115347

Marković Peković, Vanda, Ranko Škrbić, Aleksandar Petrović, Vera Vlahović Palčevski, Jana Mrak, Marion Bennie, Joseph Fadare, et al. "Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future." Expert Review of Pharmacoeconomics & Outcomes Research 16, br. 5 (2015): 609-618. https://doi.org/10.1586/14737167.2016.1115347

Marković Peković, V., et al. (2015) 'Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future', Expert Review of Pharmacoeconomics & Outcomes Research, 16(5), str. 609-618. doi: 10.1586/14737167.2016.1115347

Marković Peković V, Škrbić R, Petrović A, Vlahović Palčevski V, Mrak J, Bennie M, i sur.. Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future. Expert Review of Pharmacoeconomics & Outcomes Research [Internet]. 15.12.2015. [pristupljeno 09.05.2024.];16(5):609-618. doi: 10.1586/14737167.2016.1115347

V. Marković Peković, et al., "Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future", Expert Review of Pharmacoeconomics & Outcomes Research, vol. 16, br. 5, str. 609-618, Prosinac 2015. [Online]. Dostupno na: https://urn.nsk.hr/urn:nbn:hr:184:499506. [Citirano: 09.05.2024.]

Za citiranje koristite ovu mrežnu adresu: https://urn.nsk.hr/urn:nbn:hr:184:499506
Prijavite se u repozitorij kako biste mogli spremiti objekt u svoju listu.
Podaci o radu
Naslov (engleski)Polypharmacy among the elderly in the Republic of Srpska: extent and implications for the future
AutorVanda Marković-Peković
AutorRanko Škrbić
AutorAleksandar Petrović
AutorVera Vlahović-Palčevski
AutorJana Mrak
AutorMarion Bennie
AutorJoseph Fadare
AutorHye-Young Kwon
AutorKrijn Schiffers
AutorIlse Truter
AutorBrian Godman
Autorova ustanovaSveučilište u Rijeci
Medicinski fakultet
(Katedra za farmakologiju)
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Temeljne medicinske znanosti
Farmakologija
Znanstveno / umjetničko
područje, polje i grana		BIOMEDICINA I ZDRAVSTVO
Javno zdravstvo i zdravstvena zaštita
Obiteljska medicina
Sažetak (engleski)
The prescribing of medicines is a fundamental component of care for the elderly; however, there is increasing concern with polypharmacy and its impact on morbidity, mortality and costs. As a result, long-term prescription-medicine use and the prevalence of polypharmacy in the elderly in the Republic of Srpska were analyzed. The findings were subsequently used to suggest potential future measures. A retrospective study of all elderly patients during 2005-2010 stratified by age group (three groups), sex and long-term medicine use was performed. Polypharmacy (five or more medicines) increased from 1.4% of the elderly taking medicines long-term to 3.6% by 2010, with 53.6% of elderly taking two or more medicines long-term. The most prevalent diseases were cardiovascular diseases and diabetes. Most prescriptions were in accordance with recent guidelines; however, there was a concern with appreciable prescribing of digoxin and aminophylline. Whilst polypharmacy rates are low in the Republic, the increasing rate is a concern. Further studies are planned.
Ključne riječi (engleski)
Jezikengleski
Vrsta publikacijeZnanstveni rad - Izvorni znanstveni rad
Status objaveObjavljen
Vrsta recenzijeRecenziran - međunarodna recenzija
Verzija publikacijeZavršna verzija rukopisa prihvaćena za objavljivanje (postprint)
Naslov časopisaExpert Review of Pharmacoeconomics & Outcomes Research
Brojčani podacivol. 16, br. 5, str. 609-618
p-ISSN1473-7167
e-ISSN1744-8379
DOIhttps://doi.org/10.1586/14737167.2016.1115347
URN:NBNurn:nbn:hr:184:499506
Datum objave publikacije2015-12-15
URL dokumentahttps://www.tandfonline.com/doi/full/10.1586/14737167.2016.1115347
Vrsta resursaTekst
Prava pristupaOtvoreni pristup
Uvjeti korištenjaIkona licence Imenovanje-Nekomercijalno-Bez prerada 4.0 međunarodna (CC BY-NC-ND 4.0)
Datum i vrijeme pohrane2022-03-03 09:24:25